Skip to main content

Potential Impact Of COVID-19 On Walking Assist Devices Market

The global market is expected to witness growth in the coming years, owing to factors such as the increase in the number of initiatives undertaken by governments of various countries to ensure availability of walking assist devices to a huge consumer base, rise in aging population, and increasing incidences of Debilitating Neurological Diseases & Injuries.

The global walking assist devices market is expected to reach $6.57 Billion by 2020, at a CAGR of 3.9% from 2015 to 2020.

Walking Assist Devices Market by Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), and Region (North America, Europe, Asia-Pacific and ROW) – Global Forecast to 2020


Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=98811670

Global Walking Assist Devices Market is Segmented on:

1. Product Type
2. Geography

Product Type

Based on product, the global market is classified into gaits belts and lift vests, canes, crutches, walkers, wheelchairs, and power scooters. The wheelchairs segment of the global market is the largest and also the fastest growing segment. The rise in geriatric population across the globe and increase in the number of patients suffering from mobility impairment due to spinal cord injuries and paraplegia are some factors leading to growth of the wheelchairs segment of the global market.

Geography

The report provides a detailed analysis of the market for each region and country. Four major regions covered in the report are North America (the U.S., Canada, Mexico), Europe (Germany, France, Italy, Spain, U.K.,), and Asia-Pacific (Japan, China, India, Australia, Republic of Korea) and Rest of the World (RoW). A deep-dive analysis on pricing pattern, usage pattern, end user response matrix, market share, government initiatives, product recalls, new product launches, industry trends, and technological advancements has been detailed in the report.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=24035174

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific (APAC)
4. Rest of the World

Geographical Growth Analysis:

North America accounted for the largest share in the global walking assist devices market in 2014. The walking assist devices market in the North American region is mostly driven by factors, such as presence of supportive government policies, sophisticated healthcare infrastructure, and increasing geriatric population base. Europe is the fastest growing region in global market in 2014 due to increase in technological advancements in the healthcare sector and development of new products that are equipped with gadgets.

Some key players mentioned in the research report are:

walking assist devices market by new product launches, recent developments, and mergers & acquisitions. The major players operating in this market are Honda Motor Co., Ltd., Permobil Inc., GF Health Products, Inc., Invacare Corporation, Besco Medical Co., LTD., Betterlifehealthcare Ltd., C.T.M. Homecare Product, Inc., Ottobock, Ossenberg GmbH, Pride Mobility Products Corp., Aetna Inc., Sunrise Medical (US) LLC, and Karma Healthcare Ltd., among others.

Labels:

Comments

Post a Comment

Popular posts from this blog

Autoinjectors Market | Newest Industry Data, Future Trends and Forecast 2023

Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs. The  global autoinjectors market  is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023). In terms of Therapy, the global autoinjectors market can be segmented into: Rheumatoid Arthritis Multiple Sclerosis Diabetes Anaphylaxis Other Therapies (Cardiovascular Diseases, Migraines, Psoriasis, and Anemia) By therapy, the rheumatoid arthritis segment is expected to account for the largest share of the market in 2018 On the basis of therapy, the autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therap...
Post a Comment
Read more

Healthcare BPO Market To Reach $312.43 Billion By 2022 : Increasing Consolidation In The Healthcare Industry

  What This Report Will Provide? In the current market scenario, there is a growing demand for healthcare BPO services. The objective of this report is to define, describe, and forecast the market on the basis of outsourcing services including payer, provider, and pharmaceutical services and region. It provides detailed information regarding the major factors influencing the growth of healthcare outsourcing market. This report also tracks and analyzes competitive developments of the key players in terms of market developments, product portfolios, and financials. Expected Revenue Growth: Healthcare BPO market  is estimated to grow at a CAGR of 10.2% from 2017 to 2022 to reach $312.43 billion by 2022 from $191.68 billion in 2017. The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022. Major Growth Boosters: Patent cliffs, complex clinical trial protocols, and new reporting requirements are forcing pha...
Post a Comment
Read more

North American Nuclear Medicine Market To Reach USD 2.7 Billion By 2024 – Expansion In Emerging Economies

  What This Report Will Provide? The study involved four major activities in estimating the current size for the North American nuclear medicine market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Expected Revenue Growth: [159 Pages Report] The  North American nuclear medicine market  is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period. Major Growth Boosters: Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment...
Post a Comment
Read more